Multiple sclerosis (MS) is defined as a chronic neurological disease that affects the central nervous system, which occurs as a result of the immune system attacking nerve cells. While the “myelin sheath öneminde around the nerve cells is damaged over time; This causes disruptions in the signals transmitted from the brain and spinal cord to the body. In Türkiye, approximately 85 thousand people are diagnosed with MS. However, experts say that the number of people who have not been diagnosed due to clinical forms that are mild and insidious is also remarkable.
Neurologist Prof.Dr. Dr. Serkan Demir, MS disease in women than 2 to 3 times more than men are encountered and this is due to the more active work of the immune system in women, he says. Prof. Dr. Demir, “The treatment started in the early period, the disease is critical in terms of preventing permanent damage to the brain and spinal cord. Delayed treatment can lead to permanent neurological disability. However, although there is no definitive treatment of MS, there is a large number of treatment options to reduce the attack and to prevent disability. It can also be watched, and the use of biobelizes in the blood and brain-conjunction in the diagnostic process is becoming widespread.
One of the promising treatment methods in MS patients is the “autologous hematopoietic stem cell transplantation (AHSCT), Demir says Demir, this method is not suitable for every patient, but a multidisciplinary team is appropriate in the cases found effective results, he says.
Hematologist Dr. Hasan Atilla Özkan says that autolog stem cell transplantation is widely used especially in autoimmune diseases such as MS. Prof. Dr. Özkan emphasized that this transfer is more effective in individuals under the age of 45, with the attacks of the disease and who do not respond to other treatments, “This treatment, which can be evaluated within the scope of SSI, can be applied together with the patient approval and relevant board reports. gives.
(email protected)
